Conversion surgery for hepatocellular carcinoma with portal vein tumor thrombus after successful atezolizumab plus bevacizumab therapy: a case report

Conversion surgery for hepatocellular carcinoma with portal vein tumor thrombus after successful atezolizumab plus bevacizumab therapy: a case report

Abstract Background The treatment of hepatocellular carcinoma (HCC) requires diverse and multidisciplinary approaches. In recent years, new agents with good antitumor effects have emerged for systemic chemotherapy, and conversion surgery (CS) after systemic chemotherapy is expected to be an effectiv...

Full description

Bibliographic Details
Main Authors: Yoshifumi Hidaka, Miyo Tomita, Ryosuke Desaki, Masahiro Hamanoue, Sonshin Takao, Mari Kirishima, Takao Ohtsuka
Format: Article
Language:English
Published: BMC 2022-07-01
Series:World Journal of Surgical Oncology
Subjects:
Unresectable hepatocellular carcinoma
Portal vein tumor thrombus
Atezolizumab plus bevacizumab therapy
Conversion surgery
Case report
Online Access:https://doi.org/10.1186/s12957-022-02691-2

Internet

https://doi.org/10.1186/s12957-022-02691-2

Similar Items